Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

A field assessment of bauxite residue rehabilitation strategies.

Di Carlo E, Boullemant A, Courtney R.

Sci Total Environ. 2019 May 1;663:915-926. doi: 10.1016/j.scitotenv.2019.01.376. Epub 2019 Jan 31.

PMID:
30738270
2.

Soil properties and earthworm populations associated with bauxite residue rehabilitation strategies.

Courtney R, Di Carlo E, Schmidt O.

Environ Sci Pollut Res Int. 2018 Dec 18. doi: 10.1007/s11356-018-3973-z. [Epub ahead of print]

PMID:
30565115
3.

Anterior Segment Optical Coherence Tomography Analysis of Iris Morphometric Changes Induced by Prostaglandin Analogues Treatment in Patients with Primary Open Angle Glaucoma or Ocular Hypertension.

Mancino R, Di Carlo E, Napoli D, Martucci A, Mauro A, Rp S, Cesareo M, Nucci C.

Open Ophthalmol J. 2018 Jun 29;12:110-120. doi: 10.2174/1874364101812010110. eCollection 2018.

4.

Neurodegenerative Process Linking the Eye and the Brain.

Mancino R, Cesareo M, Martucci A, Di Carlo E, Ciuffoletti E, Giannini C, Morrone LA, Nucci C, Garaci F.

Curr Med Chem. 2018 Mar 6. doi: 10.2174/0929867325666180307114332. [Epub ahead of print]

PMID:
29521197
5.

Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization.

Sorrentino C, Ciummo SL, Cipollone G, Caputo S, Bellone M, Di Carlo E.

Cancer Res. 2018 May 15;78(10):2654-2668. doi: 10.1158/0008-5472.CAN-17-3117. Epub 2018 Feb 27.

6.

IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis.

Ferretti E, Di Carlo E, Ognio E, Fraternali-Orcioni G, Corcione A, Belmonte B, Ravetti JL, Tripodo C, Ribatti D, Pistoia V.

Oncoimmunology. 2017 Nov 27;7(3):e1397249. doi: 10.1080/2162402X.2017.1397249. eCollection 2018.

7.

Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model.

Bocca P, Di Carlo E, Caruana I, Emionite L, Cilli M, De Angelis B, Quintarelli C, Pezzolo A, Raffaghello L, Morandi F, Locatelli F, Pistoia V, Prigione I.

Oncoimmunology. 2017 Oct 4;7(1):e1378843. doi: 10.1080/2162402X.2017.1378843. eCollection 2017.

8.

EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

La Rocca F, Airoldi I, Di Carlo E, Marotta P, Falco G, Simeon V, Laurenzana I, Trino S, De Luca L, Todoerti K, Villani O, Lackmann M, D'Auria F, Frassoni F, Neri A, Del Vecchio L, Musto P, Cilloni D, Caivano A.

Cell Oncol (Dordr). 2017 Oct;40(5):483-496. doi: 10.1007/s13402-017-0338-4. Epub 2017 Jul 18.

9.

Development of a new UPLC-ESI-MS/MS method for the determination of biopterin and neopterin in dried blood spot.

Santagata S, Di Carlo E, Carducci C, Leuzzi V, Angeloni A, Carducci C.

Clin Chim Acta. 2017 Mar;466:145-151. doi: 10.1016/j.cca.2017.01.019. Epub 2017 Jan 18.

PMID:
28109742
10.

Interleukin-30 Promotes Breast Cancer Growth and Progression.

Airoldi I, Cocco C, Sorrentino C, Angelucci D, Di Meo S, Manzoli L, Esposito S, Ribatti D, Bertolotto M, Iezzi L, Natoli C, Di Carlo E.

Cancer Res. 2016 Nov 1;76(21):6218-6229. Epub 2016 Aug 22.

11.

Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.

Mauri G, Jachetti E, Comuzzi B, Dugo M, Arioli I, Miotti S, Sangaletti S, Di Carlo E, Tripodo C, Colombo MP.

Oncotarget. 2016 Jan 26;7(4):3905-20. doi: 10.18632/oncotarget.6678.

12.

Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.

Mancino R, Aiello F, Ciuffoletti E, Di Carlo E, Cerulli A, Nucci C.

BMC Ophthalmol. 2015 Dec 9;15:173. doi: 10.1186/s12886-015-0167-z.

13.

SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis.

Russo MV, Esposito S, Tupone MG, Manzoli L, Airoldi I, Pompa P, Cindolo L, Schips L, Sorrentino C, Di Carlo E.

Oncotarget. 2016 Mar 15;7(11):12372-85. doi: 10.18632/oncotarget.6029.

14.

Biofilm production in Staphylococcus epidermidis strains, isolated from the skin of hospitalized patients: genetic and phenotypic characteristics.

Calà C, Amodio E, Di Carlo E, Virruso R, Fasciana T, Giammanco A.

New Microbiol. 2015 Oct;38(4):521-9. Epub 2015 Oct 20.

15.

Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma.

Ferretti E, Di Carlo E, Ognio E, Guarnotta C, Bertoni F, Corcione A, Prigione I, Fraternali-Orcioni G, Ribatti D, Ravetti JL, Ponzoni M, Tripodo C, Pistoia V.

Oncoimmunology. 2015 Jun 19;4(10):e1030560. eCollection 2015 Oct.

16.

NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.

Carrega P, Loiacono F, Di Carlo E, Scaramuccia A, Mora M, Conte R, Benelli R, Spaggiari GM, Cantoni C, Campana S, Bonaccorsi I, Morandi B, Truini M, Mingari MC, Moretta L, Ferlazzo G.

Nat Commun. 2015 Sep 23;6:8280. doi: 10.1038/ncomms9280.

PMID:
26395069
17.

Resistance to clarithromycin and genotypes in Helicobacter pylori strains isolated in Sicily.

Fasciana T, Calà C, Bonura C, Di Carlo E, Matranga D, Scarpulla G, Manganaro M, Camilleri S, Giammanco A.

J Med Microbiol. 2015 Nov;64(11):1408-14. doi: 10.1099/jmm.0.000163. Epub 2015 Sep 2.

PMID:
26338221
18.

Upregulation of TMEM16A Protein in Bronchial Epithelial Cells by Bacterial Pyocyanin.

Caci E, Scudieri P, Di Carlo E, Morelli P, Bruno S, De Fino I, Bragonzi A, Gianotti A, Sondo E, Ferrera L, Palleschi A, Santambrogio L, Ravazzolo R, Galietta LJ.

PLoS One. 2015 Jun 29;10(6):e0131775. doi: 10.1371/journal.pone.0131775. eCollection 2015.

19.

The MUTYH base excision repair gene protects against inflammation-associated colorectal carcinogenesis.

Grasso F, Di Meo S, De Luca G, Pasquini L, Rossi S, Boirivant M, Biffoni M, Bignami M, Di Carlo E.

Oncotarget. 2015 Aug 14;6(23):19671-84.

20.

SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression.

Esposito S, Russo MV, Airoldi I, Tupone MG, Sorrentino C, Barbarito G, Di Meo S, Di Carlo E.

Oncotarget. 2015 Jul 10;6(19):17121-34.

21.

Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer.

Airoldi I, Tupone MG, Esposito S, Russo MV, Barbarito G, Cipollone G, Di Carlo E.

Oncotarget. 2015 Feb 28;6(6):3694-708.

22.

Biotin-decorated silica coated PbS nanocrystals emitting in the second biological near infrared window for bioimaging.

Corricelli M, Depalo N, Di Carlo E, Fanizza E, Laquintana V, Denora N, Agostiano A, Striccoli M, Curri ML.

Nanoscale. 2014 Jul 21;6(14):7924-33. doi: 10.1039/c4nr01025f.

PMID:
24898567
23.

Interleukin-30: A novel microenvironmental hallmark of prostate cancer progression.

Di Carlo E.

Oncoimmunology. 2014 Jan 1;3(1):e27618. Epub 2014 Jan 6.

24.

The antitumor potential of Interleukin-27 in prostate cancer.

Di Carlo E, Sorrentino C, Zorzoli A, Di Meo S, Tupone MG, Ognio E, Mincione G, Airoldi I.

Oncotarget. 2014 Nov 15;5(21):10332-41.

25.

CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.

Carrega P, Bonaccorsi I, Di Carlo E, Morandi B, Paul P, Rizzello V, Cipollone G, Navarra G, Mingari MC, Moretta L, Ferlazzo G.

J Immunol. 2014 Apr 15;192(8):3805-15. doi: 10.4049/jimmunol.1301889. Epub 2014 Mar 19.

26.

IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentation.

Morandi F, Di Carlo E, Ferrone S, Petretto A, Pistoia V, Airoldi I.

J Immunol. 2014 Mar 15;192(6):2634-42. doi: 10.4049/jimmunol.1302656. Epub 2014 Feb 19.

27.

Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens.

Bonaccorsi I, Morandi B, Antsiferova O, Costa G, Oliveri D, Conte R, Pezzino G, Vermiglio G, Anastasi GP, Navarra G, Münz C, Di Carlo E, Mingari MC, Ferlazzo G.

J Immunol. 2014 Jan 15;192(2):824-32. doi: 10.4049/jimmunol.1301039. Epub 2013 Dec 11.

28.

Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage.

Di Meo S, Airoldi I, Sorrentino C, Zorzoli A, Esposito S, Di Carlo E.

Clin Cancer Res. 2014 Feb 1;20(3):585-94. doi: 10.1158/1078-0432.CCR-13-2240. Epub 2013 Nov 25.

29.

Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.

Di Carlo E, Bocca P, Emionite L, Cilli M, Cipollone G, Morandi F, Raffaghello L, Pistoia V, Prigione I.

Mol Ther. 2013 May;21(5):1034-43. doi: 10.1038/mt.2013.38. Epub 2013 Mar 12.

30.

Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.

Zorzoli A, Di Carlo E, Cocco C, Ognio E, Ribatti D, Ferretti E, Dufour C, Locatelli F, Montagna D, Airoldi I.

Clin Cancer Res. 2012 Mar 15;18(6):1630-40. doi: 10.1158/1078-0432.CCR-11-2432. Epub 2012 Mar 1.

31.

Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.

Cocco C, Di Carlo E, Zupo S, Canale S, Zorzoli A, Ribatti D, Morandi F, Ognio E, Airoldi I.

Leukemia. 2012 Jun;26(6):1365-74. doi: 10.1038/leu.2011.363. Epub 2011 Dec 23.

PMID:
22193967
32.

Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice.

Ferretti E, Montagna D, Di Carlo E, Cocco C, Ribatti D, Ognio E, Sorrentino C, Lisini D, Bertaina A, Locatelli F, Pistoia V, Airoldi I.

Leukemia. 2012 Feb;26(2):225-35. doi: 10.1038/leu.2011.213. Epub 2011 Aug 16.

PMID:
21844875
33.

Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model.

Canale S, Cocco C, Frasson C, Seganfreddo E, Di Carlo E, Ognio E, Sorrentino C, Ribatti D, Zorzoli A, Basso G, Dufour C, Airoldi I.

Leukemia. 2011 Dec;25(12):1815-24. doi: 10.1038/leu.2011.158. Epub 2011 Jun 24.

PMID:
21701492
34.

Androgen deprivation boosts prostatic infiltration of cytotoxic and regulatory T lymphocytes and has no effect on disease-free survival in prostate cancer patients.

Sorrentino C, Musiani P, Pompa P, Cipollone G, Di Carlo E.

Clin Cancer Res. 2011 Mar 15;17(6):1571-81. doi: 10.1158/1078-0432.CCR-10-2804. Epub 2010 Dec 15.

35.

Direct inhibition of human acute myeloid leukemia cell growth by IL-12.

Ferretti E, Di Carlo E, Cocco C, Ribatti D, Sorrentino C, Ognio E, Montagna D, Pistoia V, Airoldi I.

Immunol Lett. 2010 Oct 30;133(2):99-105. doi: 10.1016/j.imlet.2010.08.002. Epub 2010 Aug 10.

PMID:
20705102
36.

Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells.

Cocco C, Canale S, Frasson C, Di Carlo E, Ognio E, Ribatti D, Prigione I, Basso G, Airoldi I.

Blood. 2010 Nov 11;116(19):3887-98. doi: 10.1182/blood-2009-10-248245. Epub 2010 Jul 29.

37.

Interleukin-27 acts as multifunctional antitumor agent in multiple myeloma.

Cocco C, Giuliani N, Di Carlo E, Ognio E, Storti P, Abeltino M, Sorrentino C, Ponzoni M, Ribatti D, Airoldi I.

Clin Cancer Res. 2010 Aug 15;16(16):4188-97. doi: 10.1158/1078-0432.CCR-10-0173. Epub 2010 Jun 29.

38.

The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al.

Airoldi I, Di Carlo E, Pistoia V.

Arthritis Rheum. 2010 Jul;62(7):2180; author reply 2180-1. doi: 10.1002/art.27484. No abstract available.

39.

Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype.

Sorrentino C, Di Carlo E.

Am J Respir Crit Care Med. 2009 Oct 15;180(8):769-79. doi: 10.1164/rccm.200903-0400OC. Epub 2009 Jul 23.

PMID:
19628777
40.

IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.

Airoldi I, Di Carlo E, Cocco C, Caci E, Cilli M, Sorrentino C, Sozzi G, Ferrini S, Rosini S, Bertolini G, Truini M, Grossi F, Galietta LJ, Ribatti D, Pistoia V.

PLoS One. 2009 Jul 1;4(7):e6119. doi: 10.1371/journal.pone.0006119.

41.

The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.

Di Carlo E, D'Antuono T, Pompa P, Giuliani R, Rosini S, Stuppia L, Musiani P, Sorrentino C.

Clin Cancer Res. 2009 May 1;15(9):2979-87. doi: 10.1158/1078-0432.CCR-08-1951. Epub 2009 Apr 14.

42.

Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.

Sangaletti S, Di Carlo E, Gariboldi S, Miotti S, Cappetti B, Parenza M, Rumio C, Brekken RA, Chiodoni C, Colombo MP.

Cancer Res. 2008 Nov 1;68(21):9050-9. doi: 10.1158/0008-5472.CAN-08-1327.

43.

Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target.

Airoldi I, Cocco C, Giuliani N, Ferrarini M, Colla S, Ognio E, Taverniti G, Di Carlo E, Cutrona G, Perfetti V, Rizzoli V, Ribatti D, Pistoia V.

Blood. 2008 Aug 1;112(3):750-9. doi: 10.1182/blood-2008-02-139378. Epub 2008 May 12.

44.

Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice.

Buanne P, Di Carlo E, Caputi L, Brandolini L, Mosca M, Cattani F, Pellegrini L, Biordi L, Coletti G, Sorrentino C, Fedele G, Colotta F, Melillo G, Bertini R.

J Leukoc Biol. 2007 Nov;82(5):1239-46. Epub 2007 Jul 26.

PMID:
17656654
45.

The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21.

Di Carlo E, Magnasco S, D'Antuono T, Tenaglia R, Sorrentino C.

Prostate. 2007 Jul 1;67(10):1070-80.

PMID:
17474076
46.

Role of IL-21 in immune-regulation and tumor immunotherapy.

di Carlo E, de Totero D, Piazza T, Fabbi M, Ferrini S.

Cancer Immunol Immunother. 2007 Sep;56(9):1323-34. Epub 2007 Apr 20. Review.

PMID:
17447063
47.

Endogenous IL-12 triggers an antiangiogenic program in melanoma cells.

Airoldi I, Di Carlo E, Cocco C, Taverniti G, D'Antuono T, Ognio E, Watanabe M, Ribatti D, Pistoia V.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3996-4001. Epub 2007 Feb 23.

48.

Inhibition of prostate carcinogenesis by combined active immunoprophylaxis.

De Giovanni C, Croci S, Nicoletti G, Landuzzi L, Palladini A, Pannellini T, Borgia L, Iezzi M, Di Carlo E, Orengo AM, Kennedy RC, Lollini PL, Nanni P, Musiani P.

Int J Cancer. 2007 Jul 1;121(1):88-94.

49.

Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections.

Di Carlo E, D'Antuono T, Contento S, Di Nicola M, Ballone E, Sorrentino C.

Am J Transplant. 2007 Jan;7(1):201-10. Epub 2006 Oct 25.

50.

The frequency of digital artery resection in Morton interdigital neurectomy.

Su E, Di Carlo E, O'Malley M, Bohne WH, Deland JT, Kennedy JG.

Foot Ankle Int. 2006 Oct;27(10):801-3.

PMID:
17054881

Supplemental Content

Loading ...
Support Center